Pharming Group reports financial results for the first quarter of 2022
Pharming Group N.V. presents its (unaudited) financial report for the first quarter of the year ended 31 March 2022.
The Company held an analyst conference call on 12 May 2022 at 13.30 CET/07.30 EST.
To launch the audio webcast recording of the call please click on this link.
Slides for the call can be downloaded below.
"The first quarter of 2022 was a key moment in the Company’s history following the report of positive data for leniolisib in a pivotal study in patients with activated phosphoinositide 3-kinase delta syndrome."- Sijmen de Vries | Chief Executive Officer